The iconic rise of Viagra has firmly established as a example of pharmaceutical success, however its legacy within the broader industry now triggers questions about long-term yields . Generic versions are undercutting exclusivity , prompting anxieties that investing in companies heavily reliant to Viagra's once-dominant position could be a speculat